Research & Development

Therapeutic Areas



An ophthalmic formulation with enhanced penetration,  potent anti-inflammatory activity and reduced dosing frequency for the treatment of inflammation and pain post ocular surgery under the regulatory 505(b)(2) pathway.



  • Discovery and early development of novel or improved antibiotics against resistant bacteria.
  • Discovery and early development of analgesics without addiction potential or side effects of opioid analgesics.